NCT04780009 Loupe-Based Intraoperative Fluorescence Imaging
| NCT ID | NCT04780009 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guoqiang Yu |
| Condition | Glioblastoma Multiforme |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2017-11-17 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2017-11-17 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA) are the most common primary malignant brain tumors. Survival of patients with these brain tumors is directly related to the extent of resection. Consequently, a great deal of effort has been directed at developing techniques and technologies that allow more extensive, safe resections. This study will test a loupe-based wearable device in the clinical setting and compare its accuracy with a large operative microscope to identify tumor tissues. Postoperative histopathological analysis on tumor tissues will be used as gold standards for comparison. The outcome from this study will be a low-cost, miniaturized, easy-to-operate, loupe-based fluorescence imaging device for intraoperative guidance of brain tumor resection with the same level of accuracy as the large microscope.
Eligibility Criteria
Inclusion Criteria: * adults with brain malignant gliomas undergoing resection * at least 18 years of age * able to understand the consent Exclusion Criteria: * pregnant women * under 18 years of age * patients undergoing emergency surgery * inability to give consent due to dysphagia or language barrier
Contact & Investigator
Guoqiang Yu, PhD
PRINCIPAL INVESTIGATOR
University of Kentucky
Frequently Asked Questions
Who can join the NCT04780009 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Glioblastoma Multiforme. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04780009 currently recruiting?
Yes, NCT04780009 is actively recruiting participants. Visit ClinicalTrials.gov or contact Guoqiang Yu to inquire about joining.
Where is the NCT04780009 trial being conducted?
This trial is being conducted at Lexington, United States.
Who is sponsoring the NCT04780009 clinical trial?
NCT04780009 is sponsored by Guoqiang Yu. The principal investigator is Guoqiang Yu, PhD at University of Kentucky. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.